Hamilton researchers have recommended treatment for rare blood clotting
From Global News Canada
https://globalnews.ca/news/7941278/hamilton-treatment-rare-blood-clots/
-snip-
"Researchers at McMaster University are recommending a pair of treatments to fight Vaccine-induced thrombotic thrombocytopenia (VITT), identified in a small number of COVID-19 vaccine recipients.
A group from the McMaster Platelet Immunology Laboratory (MPIL), building off of previous investigations into a condition that prevents blood clotting, are suggesting that a combination of anti-clotting drugs with high doses of intravenous immunoglobulin — an antibody solution — may be effective against VITT.
VITT has been associated with but not definitively linked to the viral vector shots from Oxford-AstraZeneca and Johnson & Johnson."
-snip-
For AstraZeneca first-dose recipients like myself, the risk of a clot with a second shot is orders of magnitude less than the first (which is why Canada is now only giving Astrazeneca as second doses to those who had AstraZeneca as their first, and why I'm not worried about getting my second shot of AZ).
That said, still good news - and may be applicable to clots caused by the J&J as well.
